Hyundai Bioscience

048410.KQ

3.42 USD

0.08

+2.40%

Overview

Last close

3.42 usd

Market cap

328.48M usd

52 week high

7.58 usd

52 week low

3.13 usd

Target price

N/A usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

246.4295

Price/Book Value

4.2584

Enterprise Value

300.02M usd

EV/Revenue

224.5939

EV/EBITDA

-64.6317

Key financials

Revenue TTM

1.34M usd

Gross Profit TTM

55431.45 usd

EBITDA TTM

-10.47M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

83.26M usd

Net debt

N/A usd

About

Hyundai Bioscience Co., Ltd. operates as a biotechnology company. The company provides Vitabrid C12, a vitamin C product that delivers active vitamin C into the skin. It develops Polytaxel, a drug for pancreatic cancer and solid tumors; and CP-COV03 drug for Covid 19. The company was founded in 2000 and is based in Seoul, South Korea.